Submitted by Anonymous (not verified) on 7 July 2025 - 12:40
Opinion/decision on a Paediatric investigation plan (PIP): Tezspire, tezepelumab, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Gastrointestinal disorders, PIP number: P/0281/2024
Source: